Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Prewarming Duration on Blood Flow After Colon Resection Surgery

30 settembre 2026 aggiornato da: Çiğdem Ünal Kantekin

Evaluation of the Effect of Preoperative Prewarming Duration on Postoperative Perfusion Index in Patients Undergoing Colon Resection Surgery: A Randomized Controlled Trial

This study will examine whether warming patients before colon resection surgery improves blood flow in the fingers during early recovery from general anesthesia. It will also compare two warming durations. A total of 108 adults scheduled for elective colon resection surgery at Kayseri City Hospital will be assigned by chance to one of three groups: 10 minutes of warming before anesthesia, 30 minutes of warming before anesthesia, or no active warming before anesthesia. All three groups will receive warming during surgery as part of routine care.

Warming will be provided using a forced-air warming system. After surgery, a sensor placed on a finger will measure the perfusion index, a noninvasive indicator of blood flow, on arrival in the recovery unit and 5 and 10 minutes later. The main comparison will use the average of these three measurements. The researchers will also assess other circulation measurements, routine blood gas and lactate results, shivering, pain, the time until oral feeding begins, and wound infection during the 14 days after surgery.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This prospective, single-center, randomized controlled study will be conducted by the Department of Anesthesiology and Reanimation at Kayseri City Hospital. Adults undergoing elective colon resection under general anesthesia will be randomized in a 1:1:1 ratio using a computer-generated randomization list. Allocation will be concealed in sequentially numbered, sealed opaque envelopes opened before the preoperative intervention. The planned sample size is 108 participants, with 36 participants per group.

Active prewarming will be applied in the preoperative preparation area using a forced-air warming system covering the upper and lower body. Device settings will follow manufacturer recommendations and institutional clinical standards. The two prewarming groups will receive 10 or 30 minutes of active warming before anesthesia. The control group will receive routine preoperative care without active prewarming. All groups will receive intraoperative warming and standard anesthesia monitoring and management.

Perfusion index and pleth variability index will be measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission and at 5 and 10 minutes. The primary analysis will compare the arithmetic mean of the three postoperative perfusion index measurements between groups. Arterial blood gas and lactate results will be obtained from routine clinical testing without an additional invasive procedure for research. Demographic characteristics, ASA physical status, anesthesia and surgical duration, perioperative temperature, and relevant intraoperative clinical variables will be recorded.

The primary outcome will be compared using one-way analysis of variance when distributional assumptions are met, or the Kruskal-Wallis test otherwise, with appropriate post-hoc comparisons. Repeated perfusion index measurements will also be examined for group and time effects. Secondary continuous and categorical outcomes will be analyzed with methods appropriate to their distributions. Associations of perfusion index with lactate, blood gas parameters, and pain scores will be examined using Pearson or Spearman correlation. Statistical significance will be set at p < 0.05.

The outcome assessor will be blinded to group assignment. Postoperative pain will be assessed using a 0-10 visual analogue scale at PACU admission and at 5 and 10 minutes. Wound infection will be assessed during the 14-day period following surgery.

Tipo di studio

Interventistico

Iscrizione (Stimato)

108

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Çiğdem Ünal Kantekin, MD
  • Numero di telefono: +90 505 443 3056
  • Email: drcgdm@hotmail.com

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective colon resection surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • Age younger than 18 years.
  • Emergency surgery.
  • Severe vascular disease that may affect peripheral circulation, such as advanced peripheral arterial disease.
  • Severe cardiovascular instability.
  • Fever (>38 degrees Celsius) or hypothermia (<36 degrees Celsius) before surgery.
  • Severe anemia (hemoglobin <8 g/dL).
  • Requirement for vasopressor or inotropic support.
  • A condition in the measurement limb that prevents perfusion index measurement, such as severe peripheral edema, an intravenous line, or involvement of the surgical field.
  • Refusal to participate.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: 10-Minute Prewarming

Participants receive 10 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Sperimentale: 30-Minute Prewarming

Participants receive 30 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Nessun intervento: Control: No Prewarming

Participants receive routine preoperative care without active prewarming before induction of general anesthesia. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Mean Postoperative Perfusion Index
Lasso di tempo: At PACU admission and 5 and 10 minutes after admission

Perfusion index (PI) is measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission, 5 minutes, and 10 minutes. The primary outcome is the arithmetic mean of these three measurements. PI reflects the ratio of the pulsatile to nonpulsatile component of the photoplethysmographic signal and is used as an indicator of peripheral perfusion.

At PACU admission and 5 and 10 minutes after admission

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postoperative Pleth Variability Index
Lasso di tempo: At PACU admission and 5 and 10 minutes after admission

Pleth variability index (PVI) is measured noninvasively using a pulse oximeter at PACU admission, 5 minutes, and 10 minutes to compare early postoperative changes among the three study groups.

At PACU admission and 5 and 10 minutes after admission
Postoperative Arterial Lactate
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial lactate concentration, reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission. No additional arterial sampling is performed solely for this study.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial pH
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial pH obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Carbon Dioxide Partial Pressure
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial carbon dioxide partial pressure (PaCO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Oxygen Partial Pressure
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial oxygen partial pressure (PaO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Bicarbonate
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial bicarbonate concentration (HCO3), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Base Excess
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial base excess (BE), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Hemoglobin
Lasso di tempo: At postanesthesia care unit (PACU) admission (0 minutes)

Hemoglobin concentration, reported in g/dL, recorded from routine blood gas testing at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Shivering
Lasso di tempo: From PACU admission through the first 30 minutes after admission

Number of participants with postoperative shivering. Shivering is recorded as present or absent during the first 30 minutes after postanesthesia care unit (PACU) admission.

From PACU admission through the first 30 minutes after admission
Time to Initiation of Oral Feeding
Lasso di tempo: From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery

Time from the end of surgery to the first initiation of oral feeding, recorded in hours. Participants are followed for initiation of oral feeding for up to 14 days after surgery.

From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery
Postoperative Pain Score
Lasso di tempo: At PACU admission and 5 and 10 minutes after admission

Pain intensity assessed using a visual analogue scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Scores are recorded at PACU admission, 5 minutes, and 10 minutes. Higher scores indicate greater pain.

At PACU admission and 5 and 10 minutes after admission
Wound Infection Within 14 Days After Surgery
Lasso di tempo: Within 14 days after surgery

Number of participants who develop a wound infection during the 14-day period following surgery. Wound infection is recorded as present or absent.

Within 14 days after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Çiğdem Ünal Kantekin, MD, Kayseri City Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 ottobre 2026

Completamento primario (Stimato)

15 febbraio 2027

Completamento dello studio (Stimato)

15 marzo 2027

Date di iscrizione allo studio

Primo inviato

23 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

30 settembre 2026

Primo Inserito (Effettivo)

5 ottobre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • KCH-PREWARM-2026-1080

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

Periodo di condivisione IPD

De-identified individual participant data will be available upon reasonable request beginning with publication of the primary results and continuing for 3 years after publication.

Criteri di accesso alla condivisione IPD

Researchers may request de-identified participant-level data by contacting the principal investigator, Çiğdem Ünal Kantekin, at drcgdm@hotmail.com. Requests will be considered on a reasonable-request basis.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .